Patents by Inventor Elina Armstrong

Elina Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
    Patent number: 7034105
    Abstract: The present invention provide purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind such polypeptides, and uses therefor.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: April 25, 2006
    Assignees: Licentia, Ltd., Ludwig Institute for Cancer Research
    Inventors: Kari Alitalo, Olga Aprelikova, Katri Pajusola, Elina Armstrong, Jaana Korhonen, Arja Kaipainen
  • Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
    Publication number: 20040037820
    Abstract: The present invention provide purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind such polypeptides, and uses therefor.
    Type: Application
    Filed: January 19, 2001
    Publication date: February 26, 2004
    Inventors: Kari Alitalo, Olga Aprelikova, Katri Pajusola, Elina Armstrong, Jaana Korhonen, Arja Kaipainen
  • Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
    Patent number: 6107046
    Abstract: The present invention provide purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind such polypeptides, and uses therefor.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: August 22, 2000
    Assignees: Orion Corporation, Ludwig Institute for Cancer Research
    Inventors: Karai Alitalo, Olga Aprelikova, Katri Pajusola, Elina Armstrong, Jaana Korhonen, Arja Kaipainen, Marja-Terttu Matikainien
  • FLT4, a receptor tyrosine kinase
    Patent number: 5776755
    Abstract: FLT4 gene, expression systems and proteins are provided for use in diagnosis and treatment of conditions related to the tyrosine kinase receptor encoded by the FLT4 gene.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: July 7, 1998
    Assignee: Helsinki University Licensing, Ltd.
    Inventors: Kari Alitalo, Olga Aprelikova, Katri Pajusola, Elina Armstrong, Jaana Korhonen, Arja Kaipainen